Active Ingredient(s): Brincidofovir
FDA Approved: * June 4, 2021
Pharm Company: * CHIMERIX
Category: Antiviral

Brincidofovir, sold under the brand name Tembexa, is an antiviral drug used to treat smallpox. Brincidofovir is a prodrug of cidofovir.[2] Conjugated to a lipid, the compound is designed to release cidofovir intracellularly, allowing for higher intracellular and lower plasma concentrations of cidofovir, effectively increasing its activity against dsDNA viruses, as well as oral bioavailability.[3] The most common side effects include diarrhea, nausea, vomiting, ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Tembexa 100 mg Oral Tablet, Film Coated
NDC: 79622-010
Chimerix, Inc.
Tembexa 10 mg/ml Oral Suspension
NDC: 79622-012
Chimerix, Inc.